Ask me later

Ask me later

How likely are you to recommend Redeye to a friend or colleague?

1

2

3

4

5

6

7

8

9

10

Not likely

Very likely

Not likely

1

2

3

4

5

6

7

8

9

10

Very likely

Message received

Thanks again for rating us!

Annexin Pharmaceuticals: In-Licenses Patent Rights within Cancer

2022-04-04

16:36

FT

Fredrik Thor

We give a short comment on the news that Annexin Pharmaceuticals has in-licensed a patent related to the use of Annexin A5 in cancer.

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers